Axiomer platform presentation highlighting the potential of Editing Oligonucleotides (EONs) to address liver originated disorders. Presented at the RNA Editing Gordon Research Conference on March 23, 2023 by Gerard Platenburg - ProQR Therapeutics.
This presentation highlights the therapeutic possibilities of Axiomer platform that are not limited to disease causing mutations and can potentially address high unmet medical needs by editing wild-type RNA to engineer proteins or modify their function as well as creating de novo mutations.
This is Gerard Platenburg's presentation at the 5th International Conference on Base Editing, Prime Editing & Related Enzymes (Deaminet 2024) in San Diego, California.
… ECFS on Eluforsen for F508del Cystic Fibrosis and at CFF Research Conference LEIDEN, The Netherlands, June 04, 2018 … Cystic Fibrosis Society (ECFS) conference and the CFF Research Conference. Presentation at ECFS Conference ProQR …
… scientific conferences in Salzburg, Austria – EB2017 Research Conference and ESDR Meeting. DEB is a severe genetic … EB2017 - 5 th World Conference of Epidermolysis Bullosa Research Conference from September 24-26, 2017 in Salzburg, …
… Basel, Switzerland; and the bi-annual RNA Editing Gordon Research Conference (GRC), March 19-24, 2023 in Ventura, CA, … strategy. Presentation at the RNA Editing Gordon Research Conference (GRC) Oral presentation title : …
Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Strengthened leadership with appointments of Chief Financial Officer and Chief
